NDC 70720-100-01 - QUZYTTIR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70720-100
- Requested NDC
- 70720-100-01
- Package NDCs from labels
- 70720-100-01, 70720-100-25, 70720-100-10
- Manufacturer
- TerSera Therapeutics LLC
- Effective date
- 2026-03-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| QUZYTTIR - TerSera Therapeutics LLC | TerSera Therapeutics LLC | 2026-03-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70720-100-01 | QUZYTTIR | 1 mL in 1 VIAL, GLASS | INJECTION | 1 | 8 | |
| 70720-100-10 | QUZYTTIR | 1 in 1 CARTON | INJECTION | 1 | 8 | |
| 70720-100-25 | QUZYTTIR | 25 in 1 CARTON | INJECTION | 25 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70720-100-01 | ML - Milliliter | 70720-100 | ee4a9b09-4331-4c5c-bb89-4a1f56fa9faa | 1 | 2019-12-10 |
| 70720-100-10 | ML - Milliliter | 70720-100 | 101d0bd6-4059-4bbe-880a-10938ad3d733 | 1 | 2020-06-05 |
| 70720-100-25 | ML - Milliliter | 70720-100 | 7047f5c4-027a-4798-a4d1-8d9fce348ce0 | 1 | 2019-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cetirizine Hydrochloride | CETIRIZINE HYDROCHLORIDE | Safecor Health, LLC | 734118ec-bf9a-4e58-b728-50b6c832b270 | 2026-05-01 | Warnings | 64O047KTOA |
| childrens dye free allergy relief | CETIRIZINE HCL | Kroger Company | c6660c5c-1504-4a92-95e8-cc3a018e813b | 2026-04-30 | Warnings | 64O047KTOA |
| Zyrtec | CETIRIZINE HYDROCHLORIDE | Kenvue Brands LLC | dc613bd5-70fd-1d9b-e053-2995a90a41cd | 2026-04-27 | Warnings | 64O047KTOA |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Allergy Relief | CETIRIZINE TABLETS | DISCOUNT DRUG MART, INC | 4b9576dc-d7f9-dc10-e063-6294a90a233e | 2026-04-23 | Warnings | 64O047KTOA |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| Childrens Zyrtec | CETIRIZINE HYDROCHLORIDE | Kenvue Brands LLC | 0fe77356-d945-46a0-882e-b3bbab784556 | 2026-04-22 | Warnings | 64O047KTOA |
| All Day Allergy | CETIRIZINE HYDROCHLORIDE | HyVee Inc | 8889af37-8345-4358-994d-7d8b847f4874 | 2026-04-22 | Warnings | 64O047KTOA |
| Cetirizine HCl | CETIRIZINE HCL | Meijer Distribution Inc | 3143de16-2006-ec2e-e063-6294a90a1f67 | 2026-04-20 | Warnings | 64O047KTOA |
| Cetirizine HCl | CETIRIZINE HCL | WALGREEN COMPANY | 4a181a38-ac94-8d00-e063-6394a90a6bf6 | 2026-04-20 | Warnings | 64O047KTOA |
| Cetirizine HCl | CETIRIZINE HCL | Bionpharma Inc. | 4fe8f764-a8e2-a432-e063-6294a90a33b0 | 2026-04-20 | Warnings | 64O047KTOA |
| Cetirizine HCl | CETIRIZINE HCL | TARGET Corporation | 363845a9-c379-16a7-e063-6394a90a011a | 2026-04-20 | Warnings | 64O047KTOA |
| Cetirizine HCl | CETIRIZINE HCL | KROGER COMPANY | 33f181f8-6e0d-b89b-e063-6394a90aeae7 | 2026-04-20 | Warnings | 64O047KTOA |
| Good Sense Childrens All Day Allergy | CETIRIZINE HCL | L. Perrigo Company | e56edd0e-4873-41bc-a727-05c02ec943ed | 2026-04-20 | Warnings | 64O047KTOA |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Cetirizine | CETIRIZINE HYDROCHLORIDE | Cardinal Health 107, LLC | 37c6d1e4-dd88-42a2-a828-539b68aa5dad | 2026-04-16 | Warnings | 64O047KTOA |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.